Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events
Description
CONCLUSIONS: Our review of data from clinical trials, post-marketing reports, an ongoing registry-based ELX/TEZ/IVA post-authorization safety study, and peer-reviewed literature suggests depression symptoms and depression-related events reported in
